Genmab A/S (GMAB)
51.37
-0.37
(-0.72%)
USD |
NASDAQ |
Nov 13, 16:00
52.12
+0.74
(+1.45%)
After-Hours: 06:17
Genmab Price : 51.37 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 51.22 | 51.62 | 50.68 | 51.37 | 3.733M |
| Nov 12, 2026 | 52.20 | 53.03 | 51.54 | 51.74 | 5.628M |
| Nov 11, 2026 | 52.89 | 54.09 | 52.32 | 53.87 | 3.919M |
| Nov 10, 2026 | 54.87 | 55.23 | 53.15 | 54.07 | 3.093M |
| Nov 09, 2026 | 54.36 | 55.91 | 53.32 | 55.80 | 5.137M |
| Nov 06, 2026 | 52.36 | 54.15 | 51.22 | 53.63 | 7.828M |
| Nov 05, 2026 | 55.07 | 55.27 | 52.62 | 52.74 | 4.400M |
| Nov 04, 2026 | 56.01 | 56.20 | 53.76 | 55.12 | 4.299M |
| Nov 03, 2026 | 55.46 | 56.50 | 55.10 | 55.52 | 3.061M |
| Nov 02, 2026 | 56.21 | 56.84 | 54.64 | 54.92 | 4.425M |
| Oct 30, 2026 | 57.40 | 59.02 | 56.53 | 57.06 | 8.649M |
| Oct 29, 2026 | 56.56 | 58.19 | 55.68 | 56.49 | 6.253M |
| Oct 28, 2026 | 44.63 | 59.97 | 44.35 | 57.29 | 29.28M |
| Oct 27, 2026 | 44.41 | 44.99 | 43.98 | 44.67 | 4.929M |
| Oct 26, 2026 | 44.79 | 45.44 | 44.08 | 44.68 | 7.474M |
| Oct 23, 2026 | 39.84 | 44.34 | 39.64 | 43.79 | 13.00M |
| Oct 22, 2026 | 39.68 | 40.16 | 39.50 | 40.00 | 4.686M |
| Oct 21, 2026 | 39.08 | 39.66 | 39.05 | 39.57 | 2.973M |
| Oct 20, 2026 | 38.60 | 39.40 | 38.42 | 39.07 | 3.780M |
| Oct 19, 2026 | 37.89 | 39.00 | 37.76 | 38.50 | 4.776M |
| Oct 16, 2026 | 38.14 | 38.20 | 36.74 | 37.00 | 2.685M |
| Oct 15, 2026 | 37.20 | 38.33 | 37.04 | 37.82 | 4.084M |
| Oct 14, 2026 | 36.38 | 37.24 | 36.12 | 36.89 | 2.687M |
| Oct 13, 2026 | 37.23 | 37.35 | 36.34 | 36.57 | 3.737M |
| Oct 12, 2026 | 37.18 | 37.71 | 36.94 | 37.37 | 3.128M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 295.03 |
| Incyte Corp. | 120.97 |
| Ascendis Pharma A/S | 275.39 |
| Zealand Pharma A/S | 35.50 |
| Bavarian Nordic A/S | 11.68 |
Price Related Metrics
| PE Ratio | 44.01 |
| PS Ratio | 7.630 |
| Price to Book Value | 4.988 |
| Price to Free Cash Flow | 38.87 |
| Earnings Yield | 2.27% |
| Market Cap | 31.59B |
| Operating PE Ratio | 24.91 |
| Normalized PE Ratio | 35.27 |